J&J partners with European biotech firms
October 4, 2013Research and Development, Sales and Marketing J&J, JJ, effimune, life sciences, merus
The London Johnson & Johnson Innovation Centre has teamed up with several biotech partners from the European region. Announced at …
Brintellix ‘yes’ from FDA
October 4, 2013Sales and Marketing FDA, Lundbeck, Takeda, brintellix
Takeda Pharmaceutical Company and Lundbeck are celebrating after the FDA approved their depression treatment Brintellix – despite there being no …
Lilly plans trio of launches
October 4, 2013Research and Development, Sales and Marketing lilly, pipeline
Lilly plans to launch at least three new medicines next year, senior managers announced during a meeting with analysts and …
Porter Novelli hires deputy managing director
October 4, 2013Medical Communications, Sales and Marketing Porter Novelli
PR firm Porter Novelli has announced that Fenella Grey has been named as its deputy managing director. Grey joined the …
Global cancer crisis flagged in report
October 3, 2013Medical Communications, Research and Development, Sales and Marketing IPRI, Roche, wprld prevention alliance
A new report advocates the formation of a major industry-backed initiative to tackle the world’s growing cancer burden. Sponsored by …
More companies join AZ’s BioHub
October 3, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, alderley
Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …
4C Consultants International announces two hires
October 3, 2013Medical Communications, Sales and Marketing
Deesha Majithia and Helen Jones have joined comms agency 4C Consultants International. Majithia joins the firm as a project manager …
NICE U-turn on MabThera
October 3, 2013Sales and Marketing MabThera, NHS, NICE, Roche
NICE is thinking about recommending Roche’s MabThera for a rare autoimmune condition – a move which represents a partial victory …
Merck axes 8,500 more jobs
October 2, 2013Medical Communications, Research and Development, Sales and Marketing Jobs, Merck, R&D, cuts
US shutdown starts to bite – UPDATED
October 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, FDA, Medicare, Obama, Obamacare
Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …
Calls to end UK anti-vaccine magazine
October 2, 2013Medical Communications, Sales and Marketing Cancer, Vaccine, sense about science
British retailers like Tesco and WH Smiths are being urged to drop an anti-vaccine magazine as it could be dangerous …
Hunt: ‘We will never cover up’
October 2, 2013Sales and Marketing CQC, Cameron, Hunt, NHS
In a speech which mixed the personal and the political at the Conservative Party conference in Manchester yesterday, health secretary …
TKL Research hires VP of regulatory affairs
October 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roxanne Tavakkol, TKL research
Clinical research organisation TKL Research has appointed Roxanne Tavakkol to the position of vice president, regulatory and scientific services. Tavakkol …
SHL GM Frank Isaksson signs second LOI to further increase investments in Taiwan
October 2, 2013Manufacturing and Production auto injector, frank isaksson, pen injector, shl capacity, shl expansion
SHL Group, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, signed a second Letter of …
SHL Group invests in new KraussMaffei molding machines for medical device production
October 2, 2013Manufacturing and Production auto injectors, autoinjector, pen injector, shl kraussmaffei
As SHL Group expands to provide customers with readily available services and production capabilities, the company insists on investing in …
Perjeta becomes first approved drug for early breast cancer
October 1, 2013Sales and Marketing FDA, Herceptin, Perjeta, Roche
Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …
MHRA: Cervarix ‘in clear’
October 1, 2013Sales and Marketing GSK, Gardasil, MHRA, ceravix
Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …
Merck makes big changes at the top
October 1, 2013Medical Communications, Sales and Marketing Merck, Merck Serono
Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …
Aspen buys GSK plant and thrombosis drugs for $1.1 billion
October 1, 2013Manufacturing and Production, Sales and Marketing GSK, aspen
South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …
Cancer survival rates linked to government spending in EU
October 1, 2013Research and Development, Sales and Marketing CDF, Cancer, EU, NICE
The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
